BIOMAT Database Logo BIOMAT Database Logo

Is an anti-Schistosoma haematobium vaccine necessary? 1999

R El Ridi, and A A El Garem
Zoology Department, Faculty of Science, Cairo University, Egypt. rashika@frcu.eun.eg

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012548 Schistosoma haematobium A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis. Schistosoma haematobiums,haematobiums, Schistosoma
D012553 Schistosomiasis haematobia A human disease caused by the infection of parasitic worms SCHISTOSOMA HAEMATOBIUM. It is endemic in AFRICA and parts of the MIDDLE EAST. Tissue damages most often occur in the URINARY TRACT, specifically the URINARY BLADDER. Schistosomiasis, Urinary,Schistosoma haematobia Infection,Schistosomiasis haematobium,Urinary Schistosomiasis,Urogenital Schistosomiasis,Infection, Schistosoma haematobia,Infections, Schistosoma haematobia,Schistosoma haematobia Infections,Schistosomiases, Urinary,Schistosomiases, Urogenital,Schistosomiasis, Urogenital,Urinary Schistosomiases,Urogenital Schistosomiases
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

R El Ridi, and A A El Garem
Schistosoma haematobium.
January 2023, IDCases,
R El Ridi, and A A El Garem
[Schistosoma haematobium].
January 1995, Ryoikibetsu shokogun shirizu,
R El Ridi, and A A El Garem
Schistosoma haematobium.
April 2001, The New England journal of medicine,
R El Ridi, and A A El Garem
Schistosoma haematobium.
April 2001, The New England journal of medicine,
R El Ridi, and A A El Garem
Pathology resulting from the administration of a live attenuated anti-Schistosoma haematobium vaccine in baboons.
January 1989, The American journal of tropical medicine and hygiene,
R El Ridi, and A A El Garem
Schistosoma haematobium: an unusual clinical presentation.
January 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene,
R El Ridi, and A A El Garem
A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies.
January 2013, Parasites & vectors,
R El Ridi, and A A El Garem
Mixed Schistosoma haematobium/Schistosoma intercalatum infection.
February 1990, Annals of tropical medicine and parasitology,
R El Ridi, and A A El Garem
Schistosoma haematobium in Urine Cytology: Diagnosis Is Possible.
March 2018, The American journal of medicine,
R El Ridi, and A A El Garem
Bulinus nyassanus is an intermediate host for Schistosoma haematobium in Lake Malawi.
June 2001, Annals of tropical medicine and parasitology,
Copied contents to your clipboard!